Health
Promising results from Oxford vaccine – Australian Hospital + Healthcare Bulletin
Early results from non-replicating viral vector vaccines being trialled in the UK and China reveal strong immune responses in most patients, with few adverse side effects.
There are about 250 candidate vaccines against SARS-CoV-2 in development worldwide, including mRNA vaccines, replicating or non-replicating viral vectored vaccines, DNA vaccines, autologous dendritic cell-based vaccine and inactive virus vaccines. At least 17 of them are currently under evaluation in clinical trials.
An ideal vaccine against SARS-CoV-2 should be effective after one or two vaccinations, work in target populations including older adults and those with other health conditions, con…
Continue Reading